SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (10550)10/31/1997 10:01:00 PM
From: Andrew H  Respond to of 32384
 
>>Andy, For cancer (LGND's niche area) LGND has oral and topical Targretin, oral and topical Panretin, and oral LGD1550.<<

So LGND gets all of the profits from these for cancer? I was under the impression that AGN got something. I'll go check the documents.